清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Recent advances in targeted protein degraders as potential therapeutic agents

计算生物学 生物 化学 计算机科学 组合化学
作者
Na Yang,Bo Kong,Zhaohong Zhu,Fei Huang,Zhang Li-liang,Tao Lu,Yadong Chen,Yanmin Zhang,Yulei Jiang
出处
期刊:Molecular Diversity [Springer Science+Business Media]
卷期号:28 (1): 309-333 被引量:21
标识
DOI:10.1007/s11030-023-10606-w
摘要

Targeted protein degradation (TPD) technology has gradually become widespread in the past 20 years, which greatly boosts the development of disease treatment. Contrary to small inhibitors that act on protein kinases, transcription factors, ion channels, and other targets they can bind to, targeted protein degraders could target "undruggable targets" and overcome drug resistance through ubiquitin-proteasome pathway (UPP) and lysosome pathway. Nowadays, some bivalent degraders such as proteolysis-targeting chimeras (PROTACs) have aroused great interest in drug discovery, and some of them have successfully advanced into clinical trials. In this review, to better understand the mechanism of degraders, we elucidate the targeted protein degraders according to their action process, relying on the ubiquitin-proteasome system or lysosome pathway. Then, we briefly summarize the study of PROTACs employing different E3 ligases. Subsequently, the effect of protein of interest (POI) ligands, linker, and E3 ligands on PROTAC degradation activity is also discussed in detail. Other novel technologies based on UPP and lysosome pathway have been discussed in this paper such as in-cell click-formed proteolysis-targeting chimeras (CLIPTACs), molecular glues, Antibody-PROTACs (Ab-PROTACs), autophagy-targeting chimeras, and lysosome-targeting chimeras. Based on the introduction of these degradation technologies, we can clearly understand the action process and degradation mechanism of these approaches. From this perspective, it will be convenient to obtain the development status of these drugs, choose appropriate degradation methods to achieve better disease treatment and provide basis for future research and simultaneously distinguish the direction of future research efforts. Protein is degraded by proteasome pathway and lysosome pathway.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
3秒前
7秒前
8秒前
8秒前
11秒前
冷傲太英完成签到,获得积分10
12秒前
12秒前
14秒前
英姑的应助被369ninja采纳,获得10
14秒前
17秒前
20秒前
23秒前
25秒前
科研通AI6.2的应助被369ninja采纳,获得10
36秒前
包容夏柳完成签到,获得积分10
37秒前
47秒前
酷波er的应助被初景采纳,获得10
49秒前
学霸业的应助被369ninja采纳,获得10
50秒前
沉溪完成签到,获得积分10
53秒前
着急的冷珍完成签到,获得积分10
58秒前
赘婿的应助被科研通管家采纳,获得10
1分钟前
奔跑的应助被科研通管家采纳,获得10
1分钟前
DW的应助被369ninja采纳,获得10
1分钟前
1分钟前
1分钟前
学霸业的应助被369ninja采纳,获得10
1分钟前
五月完成签到,获得积分10
1分钟前
初景发布了新的文献求助10
1分钟前
甜美的冬天完成签到,获得积分10
1分钟前
1分钟前
情怀的应助被369ninja采纳,获得10
1分钟前
大气翠风完成签到,获得积分10
1分钟前
1分钟前
Perse发布了新的文献求助10
1分钟前
orixero的应助被369ninja采纳,获得10
1分钟前
2分钟前
香蕉乐曲完成签到,获得积分10
2分钟前
2分钟前
美好的飞兰完成签到,获得积分10
2分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8179961
求助须知:如何正确求助?哪些是违规求助? 9570183
关于积分的说明 21808480
捐赠科研通 7775832
什么是DOI,文献DOI怎么找? 3433251
关于科研通互助平台的介绍 2557373
邀请新用户注册赠送积分活动 2478958